MAPT and Alzheimer disease: Western blot analysis of cell lysates revealed no changes in the levels of total tau or PHF-tau (a phosphorylated form of tau associated with AD) in neural cultures treated with 14 or 21 DIV sEVs (Figure 3A,B).